PuSH - Publication Server of Helmholtz Zentrum München

Müller, T.D.* ; Brönner, G.* ; Wandolski, M.* ; Carrie, J.* ; Nguyen, T.T.* ; Greene, B.H.* ; Scherag, A.* ; Grallert, H. ; Vogel, C.I.G.* ; Scherag, S.* ; Rief, W.* ; Wichmann, H.-E. ; Illig, T. ; Schäfer, H.* ; Hebebrand, J.* ; Hinney, A.*

Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity.

BMC Med. Genet. 11:2 (2010)
Publ. Version/Full Text Volltext DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
BACKGROUND: The orexigenic effects of cannabinoids are limited by activation of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH). The aim of this study was to analyse whether FAAH alleles are associated with early and late onset obesity. METHODS: We initially assessed association of five single nucleotide polymorphisms (SNPs) in FAAH with early onset extreme obesity in up to 521 German obese children and both parents. SNPs with nominal p-values 0.05). CONCLUSIONS: As we observed some evidence for an association of the FAAH variants rs2295632 rs324420 with early onset but not adult obesity, we conclude that the FAAH variants analyzed here at least do not seem to play a major role in the etiology of obesity within our samples.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Problem drug-use; Endocannabinoid system; Disequilibrium test; Extreme obesity; Anadamide; Polymorphism; Metabolism; Variants; Linkage; Brain
e-ISSN 1471-2350
Journal BMC Medical Genetics
Quellenangaben Volume: 11, Issue: 1, Pages: , Article Number: 2 Supplement: ,
Publisher BioMed Central
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
CCG Nutrigenomics and Type 2 Diabetes (KKG-KDN)
Research Unit Molecular Epidemiology (AME)
Institute of Diabetes and Obesity (IDO)